Table 2

Comparison in functional parameters between the two groups at 10 weeks after diagnosis and at 1-year follow-up

Functional parameter10 weeks control10 weeks MSC-treated1-year control1-year MSC-treated
HbA1c [% (mmol/mol)]6.9 ± 0.4 (52 ± 4)6.5 ± 0.4 (48 ± 4)6.6 ± 0.2 (49 ± 2)6.3 ± 0.2 (46 ± 2)
Insulin dose (IU/kg/day)0.39 ± 0.130.43 ± 0.050.37 ± 0.070.39 ± 0.05
Fasting C-peptide (nmol/L)0.28 ± 0.020.29 ± 0.050.29 ± 0.040.32 ± 0.05
  • All values are given as means ± SEM for nine patients in each group. There were no statistically significant differences between the groups.